Abstract:Background: Liver transplantation (LT) is a life-saving procedure for patients with end-stage liver disease and has become the standard and most effective treatment method for these patients. There are many indications for LT that vary between countries and settings. The outcome of LT depends on the available facilities and surgical expertise, as well as the types of liver graft donors available. Aim: To assess the clinical characteristics of patients from Bahrain who underwent LT overseas, and analyze factors affecting their survival. Methods: In this retrospective cohort study, we reviewed the medical records and overseas committee registry information of all pediatric and adult patients who were sent overseas to undergo LT by the Pediatric and Medical Departments of Salmaniya Medical Complex and Bahrain Defence Force Hospital via the Overseas Treatment Office, Ministry of Health, Kingdom of Bahrain, between 1997 and 2023. Demo graphic data, LT indication, donor-recipient relationship, overseas LT center, graft type, post-LT medications, and LT complications, were collected. Outcomes measured included the overall and 5-year LT survival rate. Fisher's exact, Pearson χ2, and Mann-Whitney U tests were used to compare the pediatric and the adults' group in terms of clinical characteristics, donor-recipient relationship, medication, complications, and outcome. Survival analysis was estimated via the Kaplan-Meier's method. Univariate and multivariate analyses were used to detect predictors of survival. Results: Of the 208 eligible patients, 170 (81.7%) were sent overseas to undergo LT while 38 (18.3%) remained on the waiting list. Of the 170 patients, 167 (80.3%) underwent LT and were included in the study. The majority of the patients were Bahraini (91.0%), and most were males (57.5%). One-hundred-and-twenty (71.8%) were adults and 47 (28.3%) were children. The median age at transplant was 50.0 [interquartile range (IQR): 14.9-58.4] years. The main indication for pediatric LT was biliary atresia (31.9%), while that of adult LT was hepatitis C-related cirrhosis (35.0%). Six (3.6%) patients required re-transplantation. Most patients received a living-related liver graft (82%). Pediatric patients received more living and related grafts than adults (P = 0.038 and P = 0.041, respectively), while adult patients received more cadaveric and unrelated grafts. Most patients required long-term immunosuppressive therapy after LT (94.7%), of which tacrolimus was the most prescribed (84.0%), followed by prednisolone (50.7%), which was prescribed more frequently for pediatric patients (P = 0.001). Most patients developed complications (62.4%) with infectious episodes being the most common (38.9%), followed by biliary stricture (19.5%). Tonsilitis and sepsis (n = 12, 8.1% for each) were the most frequent infections. Pediatric patients experienced higher rates of infection, rejection, and early poor graft function than adult patients (P < 0.001, P = 0.003, and P = 0.025, respectively). The median follow-up time was 6.5 (IQR: 2.6-10.6) years. The overall survival rate was 84.4%, the 5-year survival rate, 86.2%, and the mortality rate, 15.6%. Younger patients had significantly better odds of survival (P = 0.019) and patients who survived had significantly longer follow-up periods (P < 0.001). Conclusion: Patients with end-stage liver disease in Bahrain shared characteristics with those from other countries. Since LT facilities are not available, an overseas LT has offered them great hope.

Encouraging clinical outcomes of an international lung transplant program in the United Arab Emirates

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Initial Experience of Lung Transplantation at A Single Center in China

Lung Transplantation In China Between 2015 And 2018

A review of the lung transplantation programme in Ireland 2005-2007

A comparison of outcomes after lung transplantation between European and North American centers

Pediatric and adult liver transplantation in Bahrain: The experiences in a country with no available liver transplant facilities

A Multi‐Center International Analysis of Lung Transplantation Outcomes in Patients With COVID‐19

A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes

Three Year’s Experience of Lung Transplantation for End-stage Pulmonary Disease.

The Hidden Gem: The Costa Rica Lung Transplant Program

Management of Anesthesia during Lung Transplantations in a Single Turkish Center

Lobar Lung Transplantation: A Single-Center 10-Year Experience

Clinical Analysis of 100 Cases of Lung Transplantation for End-Stage Pulmonary Diseases

Lung transplantation for acute exacerbation of interstitial lung disease

One-Year Mortality After Lung Transplantation: Experience of a Single French Center Between 2012 and 2021

ABO-incompatible liver transplantation - exploring utilitarian solutions to restricted access and organ shortages: A single-centre experience from Johannesburg, South Africa

Limited Effect of Prevention Strategies on Incidence of Clinically Detectable Venous Thromboembolism After Lung Transplantation

Lung transplantation from donors outside standard acceptability criteria--are they really marginal?

Living-donor Lobar Lung Transplantation - Initiation and Development - Secondary Publication

Procurement Trends, Indications, and Outcomes of Heart-Lung Transplantation in the Contemporary Era